• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Mpl配体对巨核细胞生成和血小板生成的刺激作用。

Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

作者信息

de Sauvage F J, Hass P E, Spencer S D, Malloy B E, Gurney A L, Spencer S A, Darbonne W C, Henzel W J, Wong S C, Kuang W J

机构信息

Department of Molecular Biology, Genentech, South San Francisco, California 94080.

出版信息

Nature. 1994 Jun 16;369(6481):533-8. doi: 10.1038/369533a0.

DOI:10.1038/369533a0
PMID:8202154
Abstract

Physiological platelet synthesis is thought to require the humoral activities of meg-CSF and thrombopoietin, which respectively promote proliferation and maturation of megakaryocytic cells. A meg-CSF/thrombopoietin-like protein that is present in plasma of irradiated pigs has been purified and cloned. This protein binds to and activates the c-mpl protein, a member of the cytokine receptor superfamily. The isolated Mpl ligand shares homology with erythropoietin and stimulates both megakaryocytopoiesis and thrombopoiesis.

摘要

生理状态下的血小板生成被认为需要巨核细胞集落刺激因子(meg-CSF)和血小板生成素的体液活性,它们分别促进巨核细胞的增殖和成熟。一种存在于受辐照猪血浆中的类巨核细胞集落刺激因子/血小板生成素蛋白已被纯化和克隆。这种蛋白与细胞因子受体超家族成员c-mpl蛋白结合并使之激活。分离出的Mpl配体与促红细胞生成素具有同源性,并能刺激巨核细胞生成和血小板生成。

相似文献

1
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.c-Mpl配体对巨核细胞生成和血小板生成的刺激作用。
Nature. 1994 Jun 16;369(6481):533-8. doi: 10.1038/369533a0.
2
Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo.小鼠血小板生成素cDNA的克隆、表达及体内血小板生成的刺激
Nature. 1994 Jun 16;369(6481):565-8. doi: 10.1038/369565a0.
3
cMpl ligand is a humoral regulator of megakaryocytopoiesis.cMpl配体是巨核细胞生成的体液调节因子。
Nature. 1994 Jun 16;369(6481):571-4. doi: 10.1038/369571a0.
4
Thrombopoietin and the humoral regulation of thrombocytopoiesis.血小板生成素与血小板生成的体液调节
Curr Opin Hematol. 1995 May;2(3):167-71. doi: 10.1097/00062752-199502030-00002.
5
Thrombocytopenia in c-mpl-deficient mice.c-mpl基因缺陷小鼠中的血小板减少症。
Science. 1994 Sep 2;265(5177):1445-7. doi: 10.1126/science.8073287.
6
Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production.血小板生成素,即c-mpl配体,是血小板生成的主要调节因子。
J Leukoc Biol. 1995 May;57(5):719-25. doi: 10.1002/jlb.57.5.719.
7
c-mpl, the thrombopoietin receptor.c-mpl,即血小板生成素受体。
Thromb Haemost. 1995 Jul;74(1):526-8.
8
Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.血小板生成素:其受体MPL的表达及对白血病细胞的增殖作用。
Leukemia. 1996 Sep;10(9):1405-21.
9
Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.巨核细胞生成和血小板生成的进展:从基础到临床。
Br J Haematol. 2013 Jun;161(6):778-93. doi: 10.1111/bjh.12328. Epub 2013 Apr 18.
10
Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.受体MPL的表达及其配体血小板生成素对人白血病细胞的增殖作用。
Leukemia. 1996 Feb;10(2):297-310.

引用本文的文献

1
An unconquered challenge in MDS: review of pathophysiology, clinical manifestations, and management options of MDS with thrombocytopenia.骨髓增生异常综合征中一个未被攻克的挑战:血小板减少的骨髓增生异常综合征的病理生理学、临床表现及治疗选择综述
Ann Hematol. 2025 Sep 12. doi: 10.1007/s00277-025-06374-2.
2
Structural basis of MPL activation by thrombopoietin.血小板生成素激活MPL的结构基础。
Blood Vessel Thromb Hemost. 2024 Jul 16;1(3):100018. doi: 10.1016/j.bvth.2024.100018. eCollection 2024 Sep.
3
Current Advances in the Diagnosis and Treatment of Major Myeloproliferative Neoplasms.
主要骨髓增殖性肿瘤诊断与治疗的当前进展
Cancers (Basel). 2025 May 30;17(11):1834. doi: 10.3390/cancers17111834.
4
cMPL-based purification and depletion of human hematopoietic stem cells: implications for pretransplant conditioning.基于cMPL的人造血干细胞纯化与去除:对移植前预处理的影响
Blood. 2025 Jun 19;145(25):2978-2991. doi: 10.1182/blood.2024024636.
5
Decitabine facilitates thrombopoiesis independent of the thrombopoietin receptor in zebrafish.地西他滨在斑马鱼中可独立于血小板生成素受体促进血小板生成。
Blood Sci. 2025 Feb 11;7(1):e00216. doi: 10.1097/BS9.0000000000000216. eCollection 2025 Jan.
6
Avatrombopag for the Treatment of Immune Thrombocytopenia.阿伐曲泊帕用于治疗免疫性血小板减少症。
Eur J Haematol. 2025 May;114(5):733-746. doi: 10.1111/ejh.14395. Epub 2025 Feb 4.
7
LMAN1 serves as a cargo receptor for thrombopoietin.LMAN1作为血小板生成素的货物受体。
JCI Insight. 2024 Dec 20;9(24):e175704. doi: 10.1172/jci.insight.175704.
8
Systemic and local regulation of hematopoietic homeostasis in health and disease.系统和局部调节造血稳态在健康和疾病中的作用。
Nat Cardiovasc Res. 2024 Jun;3(6):651-665. doi: 10.1038/s44161-024-00482-4. Epub 2024 Jun 12.
9
Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications.用于临床应用的造血干细胞和祖细胞体外扩增的进展。
Front Bioeng Biotechnol. 2024 May 23;12:1380950. doi: 10.3389/fbioe.2024.1380950. eCollection 2024.
10
Thrombopoietin mimetic stimulates bone marrow vascular and stromal niches to mitigate acute radiation syndrome.促血小板生成素模拟物刺激骨髓血管和基质龛以减轻急性放射综合征。
Stem Cell Res Ther. 2024 Apr 29;15(1):123. doi: 10.1186/s13287-024-03734-z.